ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer / Sonpavde, G; Necchi, A; Gupta, S; Steinberg, Gd; Gschwend, Je; Van Der Heijden, Ms; Garzon, N; Ibrahim, M; Raybold, B; Liaw, D; Rutstein, M; Galsky, Md. - In: FUTURE ONCOLOGY. - ISSN 1479-6694. - 16:2(2020), pp. 4359-4368. [10.2217/fon-2019-0611]
ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer
Necchi A;
2020-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
